1. Home
  2. RZLV vs DNTH Comparison

RZLV vs DNTH Comparison

Compare RZLV & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLV
  • DNTH
  • Stock Information
  • Founded
  • RZLV 2016
  • DNTH 2015
  • Country
  • RZLV United Kingdom
  • DNTH United States
  • Employees
  • RZLV N/A
  • DNTH N/A
  • Industry
  • RZLV
  • DNTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • RZLV
  • DNTH Health Care
  • Exchange
  • RZLV NYSE
  • DNTH Nasdaq
  • Market Cap
  • RZLV 514.1M
  • DNTH 568.6M
  • IPO Year
  • RZLV N/A
  • DNTH N/A
  • Fundamental
  • Price
  • RZLV $1.92
  • DNTH $16.86
  • Analyst Decision
  • RZLV Strong Buy
  • DNTH Strong Buy
  • Analyst Count
  • RZLV 5
  • DNTH 8
  • Target Price
  • RZLV $5.20
  • DNTH $53.00
  • AVG Volume (30 Days)
  • RZLV 3.5M
  • DNTH 277.7K
  • Earning Date
  • RZLV 02-21-2025
  • DNTH 08-07-2025
  • Dividend Yield
  • RZLV N/A
  • DNTH N/A
  • EPS Growth
  • RZLV N/A
  • DNTH N/A
  • EPS
  • RZLV N/A
  • DNTH N/A
  • Revenue
  • RZLV $187,788.00
  • DNTH $6,524,000.00
  • Revenue This Year
  • RZLV $18,916.66
  • DNTH N/A
  • Revenue Next Year
  • RZLV $175.14
  • DNTH N/A
  • P/E Ratio
  • RZLV N/A
  • DNTH N/A
  • Revenue Growth
  • RZLV 29.46
  • DNTH 102.36
  • 52 Week Low
  • RZLV $1.07
  • DNTH $13.37
  • 52 Week High
  • RZLV $12.29
  • DNTH $32.27
  • Technical
  • Relative Strength Index (RSI)
  • RZLV N/A
  • DNTH 38.63
  • Support Level
  • RZLV N/A
  • DNTH $17.67
  • Resistance Level
  • RZLV N/A
  • DNTH $19.58
  • Average True Range (ATR)
  • RZLV 0.00
  • DNTH 1.14
  • MACD
  • RZLV 0.00
  • DNTH -0.07
  • Stochastic Oscillator
  • RZLV 0.00
  • DNTH 3.20

About RZLV REZOLVE AI LTD

Rezolve AI PLC is an AI-powered solutions company, specializing in enhancing customer engagement, operational efficiency, and revenue growth for the retail and e-commerce sectors. The company's product, Brain Commerce, powered by its proprietary Large Language Model (LLM) brainpowa, transforms the online shopping experience. By surpassing traditional site search and product discovery tools, Brain Commerce improves conversion rates, increases average order value (AOV), and reduces cart abandonment. The company has one reportable segment, which is cloud-based services. Geographically, the company generates revenue from Canada, the United States, Mexico, Australia, the United Kingdom, and Japan, with the majority of revenue generated from the United States.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: